US Stock MarketDetailed Quotes

IBO Impact BioMedical

Watchlist
  • 2.610
  • -0.010-0.38%
Close Nov 22 16:00 ET
  • 2.610
  • 0.0000.00%
Post 20:01 ET
30.03MMarket Cap25.84P/E (TTM)

Impact BioMedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-91.51%-1.29M
9.14%-666K
29.78%-712K
-27.16%-2.85M
-19.28%-433K
16.33%-671K
-34.74%-733K
-90.24%-1.01M
0.00%-2.24M
63.88%-363K
Net income from continuing operations
460.49%4.24M
21.25%-882K
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
49.79%-1.18M
-40.18%-1.12M
-13.81%-849K
0.00%-7.26M
37.11%-3.37M
Depreciation and amortization
0.36%281K
-0.36%279K
0.00%280K
0.63%1.12M
0.72%280K
0.36%280K
0.72%280K
0.72%280K
0.00%1.11M
0.00%278K
Deferred tax
----
----
----
--0
----
----
----
----
0.00%-621K
-378.12%-1.88M
Change In working capital
-161.50%-139K
-158.88%-63K
101.35%6K
3.56%436K
8.73%548K
4,420.00%226K
565.22%107K
-584.62%-445K
0.00%421K
39.23%504K
-Change in receivables
36.17%128K
----
----
---128K
---128K
--94K
----
----
--0
----
-Change in prepaid assets
-559.18%-323K
-129.41%-40K
97.47%-2K
273.33%104K
328.57%96K
-288.46%-49K
2,042.86%136K
-113.51%-79K
0.00%-60K
-320.00%-42K
-Change in payables and accrued expense
-69.06%56K
-135.38%-23K
102.19%8K
-4.37%460K
6.23%580K
412.07%181K
209.52%65K
-1,207.14%-366K
0.00%481K
66.46%546K
Cash from discontinued investing activities
Operating cash flow
-91.51%-1.29M
9.14%-666K
29.78%-712K
-27.16%-2.85M
-19.28%-433K
16.33%-671K
-34.74%-733K
-90.24%-1.01M
0.00%-2.24M
63.88%-363K
Investing cash flow
Cash flow from continuing investing activities
200.00%1K
109.09%1K
0
95.70%-15K
100.36%1K
0.00%-1K
-134.38%-11K
96.19%-4K
0.00%-349K
-103.37%-275K
Net PPE purchase and sale
--0
--0
--0
93.48%-18K
--0
---1K
---12K
---5K
0.00%-276K
---276K
Net investment purchase and sale
----
----
----
--0
----
----
----
----
0.00%-65K
--0
Net other investing changes
--1K
----
----
137.50%3K
0.00%1K
--0
-98.82%1K
101.08%1K
0.00%-8K
-99.98%1K
Cash from discontinued investing activities
Investing cash flow
200.00%1K
109.09%1K
--0
95.70%-15K
100.36%1K
0.00%-1K
-134.38%-11K
96.19%-4K
0.00%-349K
-103.37%-275K
Financing cash flow
Cash flow from continuing financing activities
354.02%3.95M
-10.86%665K
-29.89%713K
12.49%2.87M
-56.96%232K
12.55%870K
22.30%746K
62.72%1.02M
0.00%2.55M
107.46%539K
Net issuance payments of debt
-74.25%224K
-10.86%665K
-29.89%713K
12.49%2.87M
-56.96%232K
12.55%870K
22.30%746K
62.72%1.02M
0.00%2.55M
107.46%539K
Cash from discontinued financing activities
Financing cash flow
354.02%3.95M
-10.86%665K
-29.89%713K
12.49%2.87M
-56.96%232K
12.55%870K
22.30%746K
62.72%1.02M
0.00%2.55M
107.46%539K
Net cash flow
Beginning cash position
-33.33%2K
100.00%2K
-50.00%1K
-95.65%2K
99.01%201K
-97.71%3K
-96.97%1K
-95.65%2K
0.00%46K
8.60%101K
Current changes in cash
1,246.46%2.67M
--0
200.00%1K
97.73%-1K
-102.02%-200K
760.00%198K
-97.96%2K
92.31%-1K
0.00%-44K
-52.31%-99K
End cash Position
1,227.36%2.67M
-33.33%2K
100.00%2K
-50.00%1K
-50.00%1K
99.01%201K
-97.71%3K
-96.97%1K
0.00%2K
0.00%2K
Free cash flow
-91.22%-1.29M
10.60%-666K
30.13%-712K
-13.94%-2.87M
32.24%-433K
16.21%-672K
-36.95%-745K
-91.18%-1.02M
0.00%-2.52M
50.12%-639K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -91.51%-1.29M9.14%-666K29.78%-712K-27.16%-2.85M-19.28%-433K16.33%-671K-34.74%-733K-90.24%-1.01M0.00%-2.24M63.88%-363K
Net income from continuing operations 460.49%4.24M21.25%-882K-17.55%-998K39.26%-4.41M62.54%-1.26M49.79%-1.18M-40.18%-1.12M-13.81%-849K0.00%-7.26M37.11%-3.37M
Depreciation and amortization 0.36%281K-0.36%279K0.00%280K0.63%1.12M0.72%280K0.36%280K0.72%280K0.72%280K0.00%1.11M0.00%278K
Deferred tax --------------0----------------0.00%-621K-378.12%-1.88M
Change In working capital -161.50%-139K-158.88%-63K101.35%6K3.56%436K8.73%548K4,420.00%226K565.22%107K-584.62%-445K0.00%421K39.23%504K
-Change in receivables 36.17%128K-----------128K---128K--94K----------0----
-Change in prepaid assets -559.18%-323K-129.41%-40K97.47%-2K273.33%104K328.57%96K-288.46%-49K2,042.86%136K-113.51%-79K0.00%-60K-320.00%-42K
-Change in payables and accrued expense -69.06%56K-135.38%-23K102.19%8K-4.37%460K6.23%580K412.07%181K209.52%65K-1,207.14%-366K0.00%481K66.46%546K
Cash from discontinued investing activities
Operating cash flow -91.51%-1.29M9.14%-666K29.78%-712K-27.16%-2.85M-19.28%-433K16.33%-671K-34.74%-733K-90.24%-1.01M0.00%-2.24M63.88%-363K
Investing cash flow
Cash flow from continuing investing activities 200.00%1K109.09%1K095.70%-15K100.36%1K0.00%-1K-134.38%-11K96.19%-4K0.00%-349K-103.37%-275K
Net PPE purchase and sale --0--0--093.48%-18K--0---1K---12K---5K0.00%-276K---276K
Net investment purchase and sale --------------0----------------0.00%-65K--0
Net other investing changes --1K--------137.50%3K0.00%1K--0-98.82%1K101.08%1K0.00%-8K-99.98%1K
Cash from discontinued investing activities
Investing cash flow 200.00%1K109.09%1K--095.70%-15K100.36%1K0.00%-1K-134.38%-11K96.19%-4K0.00%-349K-103.37%-275K
Financing cash flow
Cash flow from continuing financing activities 354.02%3.95M-10.86%665K-29.89%713K12.49%2.87M-56.96%232K12.55%870K22.30%746K62.72%1.02M0.00%2.55M107.46%539K
Net issuance payments of debt -74.25%224K-10.86%665K-29.89%713K12.49%2.87M-56.96%232K12.55%870K22.30%746K62.72%1.02M0.00%2.55M107.46%539K
Cash from discontinued financing activities
Financing cash flow 354.02%3.95M-10.86%665K-29.89%713K12.49%2.87M-56.96%232K12.55%870K22.30%746K62.72%1.02M0.00%2.55M107.46%539K
Net cash flow
Beginning cash position -33.33%2K100.00%2K-50.00%1K-95.65%2K99.01%201K-97.71%3K-96.97%1K-95.65%2K0.00%46K8.60%101K
Current changes in cash 1,246.46%2.67M--0200.00%1K97.73%-1K-102.02%-200K760.00%198K-97.96%2K92.31%-1K0.00%-44K-52.31%-99K
End cash Position 1,227.36%2.67M-33.33%2K100.00%2K-50.00%1K-50.00%1K99.01%201K-97.71%3K-96.97%1K0.00%2K0.00%2K
Free cash flow -91.22%-1.29M10.60%-666K30.13%-712K-13.94%-2.87M32.24%-433K16.21%-672K-36.95%-745K-91.18%-1.02M0.00%-2.52M50.12%-639K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday+1.96%